Outsourced Pharma Webinars
-
Saving Development Time With A Single Vendor Approach
12/3/2020
This webinar provides an overview of Thermo Fisher Scientific’s Quick to CareTM program. Watch it to learn how a single-vendor with a cohesive global network can help you accelerate the drug development process and reach the market sooner.
-
How Can We Accelerate Delivery Together In The Next Stage Of Battling SARS-CoV-2?
12/2/2020
The vaccine and biotherapeutic manufacturing industries are under pressure to address critical challenges of speed, scale, and supply in its response to SARS-CoV-2. What does this mean for technologies enabling production and how does this impact the future of vaccine and biotherapeutic manufacturing?
-
Designing Efficiency Into Your AAV Process
12/2/2020
To meet your demand for high-quality adeno-associated virus (AAV) now and in the future, you need a scalable and cost-effective way to make it. Adapt this efficient process that we developed by optimizing each step from suspension cell culture to purified bulk.
-
Shortening The Timeline To First In Human (FIH) Clinical Dosage Form For Oral / Injectable Delivery
11/13/2020
Lengthy early development timelines are common across new & emerging biotech companies for a multitude of reasons. Striking the right balance of speed, quality, risk, and investment allows you to shorten timelines and work with efficiency. Strategies adopted for a rapid development of a simple yet flexible format proves beneficial.
-
The Faster Path To Self-Administration- Moving From Pre-Filled Syringe To Auto-Injector
11/5/2020
Ypsomed and Catalent Biologics share how to transition your product from pre-filled syringe to auto-injector more quickly with an experienced partner who can anticipate equipment and process needs in this on-demand webinar.
-
Achieving Biologics License Application Success Using A Structured Approach
10/28/2020
The new generation of complex biologics means drug manufacturers can no longer apply a standardized approach to development and manufacturing, such as with monoclonal antibodies. Instead, they must use a wide range of disciplines to define a product’s unique characteristics, the strategies for managing them, and the testing that needs to take place to ensure a drug consistently maintains its quality attributes from batch to batch.
-
Leveraging Innovative Technologies, Best Practices And Strategies To Accelerate Biologics Development And Commercialization
10/19/2020
Gain insight into how practical implementation of innovative technologies and solutions such as multi-attribute method, modernized cell line development workflow using high-yield cell lines and automated systems, as well as next generation purification resins help to accelerate biologics development and commercialization.
-
Inventory Management System - Choosing The Right Clinical Trial Solution For Distribution And Supply Optimization
9/24/2020
Using an IRT or IMS system can vastly improve the visibility, control and management of a clinical trial. What are the differences between them? Which solution is the most suitable for a given trial? This webinar will focus on how carefully examining clinical trial and protocol expectations will allow participants to choose the right solution for their clinical trials.
-
Considerations When Outsourcing Aseptic Fill/ Finish To A CMO
9/8/2020
This presentation addresses keys to outsourced drug production, including the importance of seeking the right partnerships to help overcome the challenges associated with secure commercial product supply.
-
Get To IND Faster
9/1/2020
Expediting development timeline is directly related to obtaining IND clearance and starting phase 1 study faster. This webinar describes how you can get to IND faster through our accelerated & high performance proprietary cell line. We will present our 3 month cell line development timeline and high quality cell line with outstanding productivity. We hope to share how our Faster & Better approach, which can be applicable to your molecule's successful development path to IND.